Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
These novel pyrazolidinyl compounds can stabilize p53 and induce apoptosis in mammalian cells through selective inhibition of ubiquitin E1. More
These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More
Treatment of Skin and Epithelial Tumors Using Intralesional Injection of Combined Antigens More
Chondroitin Sulfate / Glucosamine Hydrochloride More
Peptide vaccine to confer immunity to MUC1-expressing tumors More
Uracil DNA glycosilase (UDG or UNG) is essential for viral replication and has a key role in the generation of antibody diversity and in some anti-tumour therapies. A protein inhibiting UDG has been identified and synthesized in transformed bacteria. More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
In order to, to achieve the most active action of body energy, it is known that pH of water-containing blood should be maintained at an alkaline of 7.35 to 7.45. More
A vector to be used for transfection and purification of human soluble FcRn receptor More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Apr 2011 - 75 pages - $3,800
Nov 2010 - 330 pages - $1,495
Nov 2010 - 527 pages - $1,495
Dec 2010 - 37 pages - $500
Jul 2011 - 136 pages - $500
Feb 2011 - 209 pages - $3,500
Nov 2010 - 40 pages - $500
Dec 2010 - 22 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us